Jasna Metovic, M.D., Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Carcinoma, Neuroendocrine | 9 | 2023 | 332 | 4.490 |
Why?
|
Neuroendocrine Tumors | 9 | 2023 | 594 | 3.510 |
Why?
|
Lung Neoplasms | 11 | 2022 | 13112 | 1.190 |
Why?
|
Carcinoid Tumor | 4 | 2021 | 235 | 1.170 |
Why?
|
Thyroid Neoplasms | 5 | 2023 | 2282 | 0.860 |
Why?
|
Oxyphil Cells | 1 | 2020 | 57 | 0.740 |
Why?
|
Carcinoma, Large Cell | 1 | 2021 | 113 | 0.740 |
Why?
|
Adenocarcinoma, Follicular | 2 | 2020 | 324 | 0.730 |
Why?
|
Giant Cell Tumors | 1 | 2020 | 99 | 0.710 |
Why?
|
Acrospiroma | 1 | 2019 | 13 | 0.680 |
Why?
|
Adenoma, Oxyphilic | 1 | 2020 | 143 | 0.680 |
Why?
|
Carcinoma in Situ | 2 | 2024 | 805 | 0.660 |
Why?
|
Nipples | 2 | 2019 | 219 | 0.620 |
Why?
|
Carcinoma, Papillary | 1 | 2023 | 783 | 0.610 |
Why?
|
Artifacts | 3 | 2021 | 1904 | 0.610 |
Why?
|
Sweat Gland Neoplasms | 1 | 2019 | 108 | 0.600 |
Why?
|
Breast Neoplasms | 9 | 2023 | 20827 | 0.590 |
Why?
|
Carcinoma, Lobular | 1 | 2021 | 484 | 0.560 |
Why?
|
Specimen Handling | 1 | 2021 | 694 | 0.540 |
Why?
|
Repressor Proteins | 3 | 2022 | 3024 | 0.530 |
Why?
|
Cytodiagnosis | 1 | 2019 | 435 | 0.510 |
Why?
|
Lung | 5 | 2021 | 9858 | 0.510 |
Why?
|
Immunity | 1 | 2020 | 1013 | 0.490 |
Why?
|
Immunohistochemistry | 6 | 2021 | 11360 | 0.450 |
Why?
|
Pancreatic Neoplasms | 4 | 2024 | 5264 | 0.430 |
Why?
|
Bone Neoplasms | 2 | 2021 | 2529 | 0.390 |
Why?
|
Adenoma | 1 | 2019 | 2173 | 0.310 |
Why?
|
Prognosis | 10 | 2023 | 29052 | 0.280 |
Why?
|
Receptors, Estrogen | 3 | 2019 | 2190 | 0.200 |
Why?
|
Receptors, Androgen | 2 | 2018 | 1055 | 0.200 |
Why?
|
Struma Ovarii | 1 | 2020 | 10 | 0.190 |
Why?
|
Humans | 37 | 2024 | 743811 | 0.190 |
Why?
|
Neoplasm Staging | 5 | 2021 | 11036 | 0.180 |
Why?
|
Choristoma | 1 | 2021 | 213 | 0.170 |
Why?
|
Italy | 1 | 2021 | 829 | 0.170 |
Why?
|
Bronchoalveolar Lavage | 1 | 2019 | 120 | 0.170 |
Why?
|
Adrenal Glands | 1 | 2021 | 547 | 0.160 |
Why?
|
Carcinoma, Small Cell | 1 | 2020 | 420 | 0.160 |
Why?
|
Intestinal Neoplasms | 1 | 2021 | 319 | 0.160 |
Why?
|
Hedgehog Proteins | 1 | 2023 | 784 | 0.160 |
Why?
|
Carcinoma, Signet Ring Cell | 1 | 2018 | 83 | 0.160 |
Why?
|
Tumor Escape | 1 | 2020 | 350 | 0.150 |
Why?
|
Hepatocyte Nuclear Factor 3-alpha | 1 | 2018 | 170 | 0.150 |
Why?
|
Pleural Effusion, Malignant | 1 | 2018 | 101 | 0.150 |
Why?
|
Hyperplasia | 1 | 2021 | 1185 | 0.150 |
Why?
|
Microarray Analysis | 1 | 2020 | 765 | 0.150 |
Why?
|
Ki-67 Antigen | 1 | 2019 | 644 | 0.150 |
Why?
|
Sputum | 1 | 2019 | 476 | 0.140 |
Why?
|
Pericardial Effusion | 1 | 2018 | 247 | 0.140 |
Why?
|
Amyloid | 1 | 2021 | 795 | 0.140 |
Why?
|
Thymus Neoplasms | 1 | 2018 | 268 | 0.140 |
Why?
|
Middle Aged | 15 | 2023 | 213241 | 0.130 |
Why?
|
Neuroblastoma | 1 | 2023 | 1226 | 0.130 |
Why?
|
DNA Helicases | 1 | 2021 | 861 | 0.130 |
Why?
|
Neoplasm Invasiveness | 2 | 2021 | 3617 | 0.130 |
Why?
|
Osteosarcoma | 1 | 2021 | 881 | 0.130 |
Why?
|
Aged, 80 and over | 7 | 2021 | 57744 | 0.130 |
Why?
|
Fatty Liver | 1 | 2020 | 728 | 0.120 |
Why?
|
Biopsy, Fine-Needle | 1 | 2019 | 1094 | 0.120 |
Why?
|
Breast | 1 | 2023 | 1970 | 0.120 |
Why?
|
Thymus Gland | 1 | 2018 | 1266 | 0.110 |
Why?
|
Bronchoscopy | 1 | 2019 | 861 | 0.110 |
Why?
|
Transcription Factors | 3 | 2022 | 12209 | 0.110 |
Why?
|
DNA Mutational Analysis | 2 | 2021 | 4183 | 0.110 |
Why?
|
Carcinoma, Pancreatic Ductal | 1 | 2024 | 1637 | 0.110 |
Why?
|
Female | 19 | 2023 | 380020 | 0.110 |
Why?
|
Down-Regulation | 1 | 2020 | 3000 | 0.110 |
Why?
|
Intracellular Signaling Peptides and Proteins | 1 | 2022 | 2914 | 0.100 |
Why?
|
Stomach Neoplasms | 1 | 2021 | 1332 | 0.100 |
Why?
|
Immune Tolerance | 1 | 2020 | 2258 | 0.100 |
Why?
|
Retrospective Studies | 9 | 2021 | 77410 | 0.100 |
Why?
|
Up-Regulation | 1 | 2020 | 4221 | 0.090 |
Why?
|
Aged | 9 | 2021 | 163178 | 0.090 |
Why?
|
Trans-Activators | 1 | 2019 | 2927 | 0.090 |
Why?
|
Bone and Bones | 1 | 2020 | 2576 | 0.080 |
Why?
|
Liver Transplantation | 1 | 2020 | 2119 | 0.080 |
Why?
|
Survival Analysis | 1 | 2021 | 10251 | 0.080 |
Why?
|
Membrane Proteins | 2 | 2022 | 7880 | 0.080 |
Why?
|
Genomics | 2 | 2021 | 5714 | 0.080 |
Why?
|
Ultrasonography | 1 | 2020 | 5986 | 0.070 |
Why?
|
Nuclear Proteins | 1 | 2021 | 5854 | 0.070 |
Why?
|
Sensitivity and Specificity | 1 | 2021 | 14714 | 0.070 |
Why?
|
Cell Differentiation | 1 | 2022 | 11478 | 0.060 |
Why?
|
Predictive Value of Tests | 1 | 2021 | 15067 | 0.060 |
Why?
|
Neoplasm Recurrence, Local | 2 | 2020 | 9239 | 0.060 |
Why?
|
Adult | 9 | 2021 | 213889 | 0.060 |
Why?
|
Gene Expression Regulation, Neoplastic | 1 | 2020 | 8430 | 0.060 |
Why?
|
Reproducibility of Results | 1 | 2022 | 19894 | 0.060 |
Why?
|
MicroRNAs | 1 | 2020 | 3750 | 0.060 |
Why?
|
Gene Expression Profiling | 1 | 2020 | 9440 | 0.060 |
Why?
|
Diagnosis, Differential | 1 | 2019 | 12954 | 0.060 |
Why?
|
Ovarian Neoplasms | 1 | 2020 | 4839 | 0.060 |
Why?
|
Male | 10 | 2021 | 349776 | 0.050 |
Why?
|
Infant, Newborn | 1 | 2022 | 25609 | 0.050 |
Why?
|
DNA-Binding Proteins | 1 | 2019 | 9648 | 0.050 |
Why?
|
Caloric Restriction | 1 | 2023 | 302 | 0.050 |
Why?
|
Activating Transcription Factor 2 | 1 | 2020 | 45 | 0.050 |
Why?
|
Janus Kinase 3 | 1 | 2020 | 78 | 0.050 |
Why?
|
Mutation | 3 | 2021 | 29777 | 0.050 |
Why?
|
Follow-Up Studies | 1 | 2021 | 39001 | 0.040 |
Why?
|
Activin Receptors, Type II | 1 | 2020 | 127 | 0.040 |
Why?
|
Disease-Free Survival | 2 | 2020 | 6895 | 0.040 |
Why?
|
Neoplasms | 2 | 2018 | 21675 | 0.040 |
Why?
|
Receptor, erbB-2 | 2 | 2019 | 2418 | 0.040 |
Why?
|
Preoperative Period | 1 | 2020 | 550 | 0.040 |
Why?
|
Geography | 1 | 2020 | 669 | 0.040 |
Why?
|
Pathology, Molecular | 1 | 2021 | 326 | 0.040 |
Why?
|
GTP Phosphohydrolases | 1 | 2020 | 508 | 0.040 |
Why?
|
Kruppel-Like Transcription Factors | 1 | 2020 | 505 | 0.040 |
Why?
|
High-Throughput Nucleotide Sequencing | 2 | 2020 | 3591 | 0.040 |
Why?
|
Antigens, Neoplasm | 1 | 2023 | 1988 | 0.030 |
Why?
|
Adolescent | 2 | 2021 | 85729 | 0.030 |
Why?
|
Receptors, Progesterone | 1 | 2019 | 1098 | 0.030 |
Why?
|
Molecular Diagnostic Techniques | 1 | 2019 | 602 | 0.030 |
Why?
|
Cell Transformation, Neoplastic | 1 | 2024 | 2942 | 0.030 |
Why?
|
Case-Control Studies | 2 | 2023 | 21733 | 0.030 |
Why?
|
Young Adult | 1 | 2020 | 56392 | 0.030 |
Why?
|
Thyroid Gland | 1 | 2020 | 1173 | 0.030 |
Why?
|
Cluster Analysis | 1 | 2021 | 2712 | 0.030 |
Why?
|
Fatal Outcome | 1 | 2018 | 1851 | 0.030 |
Why?
|
Staining and Labeling | 1 | 2017 | 1098 | 0.030 |
Why?
|
Neoplasms, Second Primary | 1 | 2021 | 1063 | 0.030 |
Why?
|
ras Proteins | 1 | 2018 | 1059 | 0.030 |
Why?
|
Neoadjuvant Therapy | 1 | 2023 | 2727 | 0.030 |
Why?
|
DNA, Neoplasm | 1 | 2018 | 1758 | 0.030 |
Why?
|
Adenocarcinoma | 2 | 2021 | 6363 | 0.030 |
Why?
|
Lymph Nodes | 1 | 2023 | 3476 | 0.030 |
Why?
|
Cell Nucleus | 1 | 2020 | 2969 | 0.020 |
Why?
|
Oncogene Proteins, Fusion | 1 | 2019 | 1581 | 0.020 |
Why?
|
Gene Frequency | 1 | 2018 | 3585 | 0.020 |
Why?
|
Proto-Oncogene Proteins B-raf | 1 | 2020 | 2039 | 0.020 |
Why?
|
Animals | 1 | 2020 | 168660 | 0.020 |
Why?
|
Protein Kinase Inhibitors | 1 | 2023 | 5532 | 0.020 |
Why?
|
Cell Line, Tumor | 1 | 2023 | 16674 | 0.020 |
Why?
|
Alleles | 1 | 2018 | 6934 | 0.020 |
Why?
|
Sequence Analysis, DNA | 1 | 2018 | 4803 | 0.020 |
Why?
|
Biopsy | 1 | 2018 | 6750 | 0.020 |
Why?
|
T-Lymphocytes | 1 | 2023 | 10179 | 0.020 |
Why?
|
Proportional Hazards Models | 1 | 2019 | 12354 | 0.020 |
Why?
|
Prevalence | 1 | 2021 | 15211 | 0.020 |
Why?
|
Cell Proliferation | 1 | 2019 | 10477 | 0.010 |
Why?
|
Carcinoma, Squamous Cell | 1 | 2019 | 4033 | 0.010 |
Why?
|
Image Processing, Computer-Assisted | 1 | 2020 | 8939 | 0.010 |
Why?
|
Algorithms | 1 | 2020 | 13869 | 0.010 |
Why?
|
Tomography, X-Ray Computed | 1 | 2018 | 20121 | 0.010 |
Why?
|
Treatment Outcome | 1 | 2020 | 63042 | 0.010 |
Why?
|
Child | 1 | 2021 | 77637 | 0.010 |
Why?
|